An Efficient Treatment for Posttraumatic Injury for Firefighters
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Posttraumatic Stress Disorder
- Sponsor
- Palo Alto Veterans Institute for Research
- Enrollment
- 49
- Locations
- 1
- Primary Endpoint
- Structured Clinical Interview for DSM-5 Sleep Disorders- Revised (SCISD-R)
- Status
- Completed
- Last Updated
- 11 months ago
Overview
Brief Summary
The goal of this two-arm pilot randomized controlled trial is to test a behavioral intervention that integrates three evidence-based cognitive behavioral interventions (written exposure therapy; WET, cognitive behavioral therapy for insomnia; CBT-I, and cognitive behavioral therapy for nightmares; CBT-N) among firefighters. The main questions it aims to answer are:
- Is the behavioral intervention feasible, acceptable, and effective in reducing symptoms of posttraumatic stress, insomnia, and nightmares?
- What is the efficacy of efficient treatment vs. delayed treatment (2-4 week waitlist) in reducing symptoms of posttraumatic stress, insomnia, and nightmares?
We will beta test the intervention in 1-2 groups of 3-5 firefighters. Then we will randomize 50 participants to immediate or delayed (2-4 week waitlist) treatment. Consented participants will:
- Complete self-report and interview measures assessing posttraumatic stress disorder, insomnia (PTSD), and nightmares
- Attend an individual treatment orientation session
- Attend a 4-day (~3 hours per day over 4 consecutive days) group treatment that integrates WET, CBT-I, and CBT-N
- Attend an individual booster session held approximately one week later
- Complete self-report measures before, during, and after treatment, and at a 3-month follow up assessment and a clinical interview before and after treatment to assess program efficacy.
Investigators
Carmen McLean
Clinical Psychologist
Palo Alto Veterans Institute for Research
Eligibility Criteria
Inclusion Criteria
- •18-65 years old
- •Firefighter
- •Able to speak and read English
- •Clinically significant posttraumatic stress symptoms: CAPS-5 total score ≥ 25; ≥ 1 intrusion symptom; ≥ 1 avoidance symptom
- •Clinically significant symptoms of insomnia: SCISD insomnia criteria are met; ISI ≥ 15
- •Clinically significant symptoms of nightmare disorder: SCISD nightmare disorder criteria are met, nightmares ≥ 1 monthly.
Exclusion Criteria
- •Current suicide or homicide risk meriting crisis intervention
- •Inability to speak and read English
- •Inability to comprehend the baseline screening questionnaires
- •Unwilling to remain abstinent from alcohol during treatment
- •Serious mental health diagnosis such as bipolar disorder or psychosis.
Outcomes
Primary Outcomes
Structured Clinical Interview for DSM-5 Sleep Disorders- Revised (SCISD-R)
Time Frame: Change from baseline to post treatment (~4 weeks post baseline)
The SCISD-R is a semi-structured interview designed to obtain a sleep history and screen for certain sleep disorders and diagnose others, including insomnia, hypersomnia, circadian rhythm sleep-wake disorders, sleep-disordered breathing, and parasomnias.
Insomnia Severity Index (ISI)
Time Frame: Change from baseline through 3 months post treatment
The ISI assesses perceived severity of insomnia.
Nightmare Disorders Index
Time Frame: Change from baseline through 3 months post treatment
The NDI is a self-report assessment of nightmare disorder.
Clinician Administered PTSD Scale (CAPS-5)
Time Frame: Change from baseline to post treatment (~4 weeks post baseline)
The CAPS-5 is a structured clinical interview that assesses the presence and severity of PTSD symptoms.
Posttraumatic Stress Disorder Checklist (PCL-5)
Time Frame: Change from baseline through 3 months post treatment
Self-report measure update of the PCL designed to assess PTSD symptoms as defined by the DSM-5.
Secondary Outcomes
- Sleep Diary and Nightmare Log(Change from baseline through post treatment (~4 weeks post baseline))
- Trauma-Related Nightmare Survey (TRNS)(Change from baseline through 3 months post treatment)
- Patient Health Questionnaire-9 (PHQ-9)(Change from baseline through 3 months post treatment)
- Depressive Symptoms Index-Suicidality Subscale (DSI-SS)(Change from baseline through 3 months post treatment)
- Self-Assessment of Sleep (SASS)(Change from baseline through 3 months post treatment)
- Net Prompter Score(Post treatment (~4 weeks post baseline))